November 17, 2021
Dr. Derek So presented the late-breaking results of the trial “Reassessment of Anti-Platelet Therapy Using InDividualized Strategies - Ticagrelor in Patients With Acute Coronary Syndromes Treated by Coronary Artery Bypass Graft Surgery (RAPID CABG)” at the American Heart Association’s Scientific Sessions 2021 on November 13.
According to the research, people who are on the antiplatelet medication ticagrelor and need coronary artery bypass surgery may be able to safely have the procedure after waiting less time than typically recommended after the medication is stopped. This may also decrease hospital length of stay.
Media contact
Sitraka Raoelimanohisoa
Coordinator, Communications
University of Ottawa Heart Institute
sraoelimanohisoa@ottawaheart.ca